Microbot Medical (MBOT) Accounts Payables (2010 - 2026)

Microbot Medical has reported Accounts Payables for 17 years, with the latest figure at $1.1 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables rose 483.33% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 483.33% YoY), and the FY2025 full-year result was $511000.0, up 209.7% from the prior year.
• Accounts Payables for Q1 2026 stood at $1.1 million, up from $511000.0 in the prior quarter.
• The five-year high for Accounts Payables was $1.1 million in Q1 2026, with the low at $96000.0 in Q1 2024.
• Historically, Accounts Payables has averaged $316823.5 across 5 years, with a median of $238000.0 in 2023.
• Annual changes were most pronounced in 2022 — Accounts Payables sank 58.42% — and 2026, when it soared 483.33%.
• Microbot Medical's Accounts Payables stood at $116000.0 in 2022, then surged by 207.76% to $357000.0 in 2023, then plunged by 53.78% to $165000.0 in 2024, then soared by 209.7% to $511000.0 in 2025, then soared by 112.33% to $1.1 million in 2026.
• The last three Accounts Payables figures came in at $1.1 million (Q1 2026), $511000.0 (Q4 2025), and $509000.0 (Q3 2025), per Business Quant data.